Head-to-Head

Johnson & Johnson vs. Ocular Therapeutix, Inc.

JNJ

Johnson & Johnson

$259.25 -2.08%

VS OCUL

Ocular Therapeutix, Inc.

$7.29 -4.95%

Johnson & Johnson (JNJ) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

JNJOCUL
Market Cap $638.00 billion $1.68 billion

JNJ leads on 1 of 1 size & scale factors.

Dividend

JNJOCUL
Dividend Yield 2.07% —

JNJ and OCUL split the dividend factors evenly.

Risk & Sentiment

JNJOCUL
Short Interest 0.67% 1.47%

JNJ leads on 1 of 1 risk & sentiment factors.

Dig deeper: JNJ overview, JNJ financials, OCUL overview, OCUL financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.